Saving Hearts, Kidneys and Lives: Exploring Dapagliflozin Pleiotropic Effects on Cardiovascular and Renal Functions

Saving Hearts, Kidneys and Lives: Exploring Dapagliflozin Pleiotropic Effects on Cardiovascular and Renal Functions

NephrologyCardiologyEndocrinologyInternal MedicineGeneral Practice
A badge with ribbon in color black CPD Unit: 1 Point | An analog clock in color black 38 Minutes | A black calendar with white triangle in center that has a black exclamation point in the middle 01 Jan 2026 

Overview

About

This video-on-demand learning module will discuss some common clinical questions encountered in the use of Dapagliflozin (Forxiga) in the management of diabetes focusing on its pleiotropic effects and how it impacts cardiovascular, renal and mortality outcomes.

Learning outcomes

  1. Understand the evidence on the life-saving effect of dapagliflozin on CKD and heart failure patients.
  2. Understand the evidence on the continued use of dapagliflozin even with deterioration of eGFR in patients with CKD.
  3. Understand the CKD-preventive effect of dapagliflozin.
  4. Understand the difference in the evidence on efficacy of dapagliflozin (Forxiga) compared to generic dapagliflozin.

Topic covered: Use and efficacy of dapagliflozin in patients with diabetes and CKD and cardiovascular diseases

1 CPD Point Available

  • Score at least 80% on the quiz.
  • A certificate can be downloaded upon successful completion. Please use the information on the certificate to claim your CPD points.
Something went wrong.